about
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseThe neurobiological link between OCD and ADHDReal-time impedance-based cell analyzer as a tool to delineate molecular pathways involved in neurotoxicity and neuroprotection in a neuronal cell line.Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive-compulsive disorder.Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder studyAssociation study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism.Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptomsGenes and oxidative stress in parkinsonism: cDNA microarray studies.Preclinical versus clinical neuroprotection.Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.Neuroprotective strategies in Parkinson's disease : an update on progress.Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene.Monoamine oxidase-B inhibition in Alzheimer's disease.The benefits of microarrays as tools for studying neuropsychiatric disorders.Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study.pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.A molecular signature in blood identifies early Parkinson's disease.DNA methylation profiles of elderly individuals subjected to indentured childhood labor and traumaGenomic aspects of sporadic Parkinson's disease.Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta.Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?The link between iron, metabolic syndrome, and Alzheimer's disease.Parkinson's disease: molecular risk factors.In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?Imaging genetics in obsessive-compulsive disorder: linking genetic variations to alterations in neuroimaging.Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals.Effects of oxytocin and arginine vasopressin on the proliferation and differentiation of a serotonergic cell line.The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.
P50
Q24597726-3D8E52A5-ED02-4DE1-BBB5-2D49C29C9530Q27002629-E2FA5BB9-B79C-4EAC-AF3D-2328885E158AQ27302931-B3F15C25-E991-40C4-802C-1B6336077F7EQ31114020-40A260C2-A7D9-45D9-BEC4-43C3D44160EFQ33223171-3464A406-7559-4992-AE13-F16AA1878AC4Q33843524-B5C2F4AF-2031-415E-A9C7-D8A85089F6EDQ34080209-97BD29D7-FFDA-4A31-8373-3391FA5154EAQ34206852-C6A13823-F522-406F-A0C4-7CC9DFFD8D8AQ34445382-81B18C56-B3F4-40FC-AF11-2308DCFE8AA8Q34470381-C4819C11-E793-4EE1-8959-CB58C17DF4F5Q34807118-C8EFE90D-7844-4967-8D10-3E9C488B7C2BQ34850070-351AFEED-C871-42D9-9837-B99337C4E5AEQ35004705-2290C999-5B50-4445-AEE0-43F1C1B442C1Q35004813-0D73F4F5-F5CF-40E4-B4F7-1AB17A5E63B1Q35025664-3028549A-2886-4DFD-8EAD-B5352B28C4FEQ35066231-C883C65A-F1CB-4DFA-9ABC-01A2F56ED4B9Q35182054-CF7A1CFA-0C32-4C87-86B7-EC49920EE872Q35208018-DB7EC865-5109-4987-AA10-61C5C19D28FDQ35617449-7A3583B1-E1F3-43B5-AF45-DADB50FD7DF0Q35715644-01F94C87-2BE7-42BD-8A84-4575A4D14C08Q35776248-67C5E9C2-6433-4BCE-9894-1BD206FAE0C8Q35884924-D771F9B5-54AF-4C91-AFFD-BA9CF33C3D96Q35940273-2B399FDA-891A-431B-90DE-310AB85B8BD1Q36179021-56E71B08-265E-4922-A411-7F33D5EE45F9Q36292063-BD0EDB46-0270-4175-9074-EE0763390ED6Q37201708-FC38A7EA-22F1-4A1C-AB0E-A3D1FF3B8A94Q37352061-88C33BF3-E1B8-4210-9DF7-580C24D911B3Q37574774-7B0C9612-3381-42E9-8F53-474595A8CBA0Q37686937-D4DF11F7-C758-4159-ADD2-96A211F76381Q37765503-54EA39F9-C249-4615-AFF6-A03A8924E6CDQ37765832-E0A53C45-697A-4EF1-A433-D217624AD9C8Q37968075-C237A0F8-58D5-49D7-B7C7-E02EF3232365Q38029532-3297C210-2C25-4D53-83B6-8D633B474010Q38100688-531EB120-0415-4BC7-8EF8-06FF707D7BA5Q38232231-CF7EDEFB-80C7-4E49-9F85-39BA12912DB4Q38258298-D5B2576F-3C5A-4096-AFBB-0324025AF3E3Q38296680-0D5F6B09-60C8-43D0-A4AB-D87704D6D9AEQ38694598-E3472FA3-94F2-416D-88CE-0B800DAFACF6Q38711637-125ACF8B-11E4-4F79-9F67-6B75416D5B77Q38805367-1ED284A3-D8A3-4194-956D-8EF21E81AF65
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Edna Grünblatt
@ast
Edna Grünblatt
@en
Edna Grünblatt
@es
Edna Grünblatt
@nl
Edna Grünblatt
@sl
type
label
Edna Grünblatt
@ast
Edna Grünblatt
@en
Edna Grünblatt
@es
Edna Grünblatt
@nl
Edna Grünblatt
@sl
altLabel
E Grünblatt
@en
Grünblatt Edna
@en
prefLabel
Edna Grünblatt
@ast
Edna Grünblatt
@en
Edna Grünblatt
@es
Edna Grünblatt
@nl
Edna Grünblatt
@sl
P1053
A-6762-2016
P106
P1153
56437784000
6603624174
P21
P2798
P31
P3829
P3835
edna-grnblatt
P4012
P496
0000-0001-8505-7265